I
107TH CONGRESS
1ST SESSION
H. R. 1672
To provide for an increase in funding for research on uterine fibroids through
the National Institutes of Health, and to provide for a program to
provide information and education to the public on such fibroids.
IN THE HOUSE OF REPRESENTATIVES
MAY 2, 2001
Mrs. JONES of Ohio (for herself, Mrs. CHRISTENSEN, Mr. JEFFERSON, Ms.
LEE, Mr. MEEKS of New York, Mr. RUSH, Mr. SCOTT, Mr. HILLIARD,
Ms. EDDIE BERNICE JOHNSON of Texas, Ms. KAPTUR, Mr. PAYNE, Ms.
MCKINNEY, Mr. CONYERS, Ms. JACKSON-LEE of Texas, Mr. LEWIS of
Georgia, Mrs. CLAYTON, Mr. OWENS, Mr. WYNN, Ms. PELOSI, Mrs.
LOWEY, Ms. DELAURO, Mr. JACKSON of Illinois, Ms. NORTON, Ms.
WOOLSEY, Mr. FRANK, Mr. BROWN of Ohio, Ms. SLAUGHTER, Mr. DAVIS
of Illinois, Mr. FILNER, Mr. HASTINGS of Florida, Mr. DINGELL, Mr.
CUMMINGS, Mr. WEXLER, Mr. THOMPSON of Mississippi, Mr. CAPUANO,
Mrs. MEEK of Florida, Mr. FROST, and Mr. GONZALEZ) introduced the
following bill; which was referred to the Committee on Energy and Com-
merce
A BILL
To provide for an increase in funding for research on uterine
fibroids through the National Institutes of Health, and
to provide for a program to provide information and
education to the public on such fibroids.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘Uterine Fibroids Re-
search and Education Act of 2001’’.
SEC. 2. FINDINGS.
The Congress finds as follows:
(1) The development of uterine fibroids is a
common and significant health problem, affecting
women of all ages, racial backgrounds, and socio-
economic levels.
(2) It has been estimated that between 20 and
30 percent of women of reproductive age have such
fibroids, though not all have been diagnosed. Studies
indicate the prevalence could be much higher.
(3) Uterine fibroids are the most common indi-
cation for hysterectomy, accounting for approxi-
mately one third of hysterectomies, or 200,000 pro-
cedures annually.
(4) Such fibroids are the leading indication of
hysterectomy among premenopausal women in the
United States.
SEC. 3. PUBLIC HEALTH PROGRAMS REGARDING UTERINE
FIBROIDS.
(a) RESEARCH THROUGH NATIONAL INSTITUTES OF
HEALTH.—In addition to other authorizations of appro-
priations that are available for the purpose of conducting
and supporting research on uterine fibroids through the
National Institutes of Health, there is authorized to be
appropriated for such purpose $10,000,000 for each of the
fiscal years 2002 through 2006.
(b) PUBLIC AWARENESS.—
(1) IN GENERAL.—The Secretary of Health and
Human Services (in this subsection referred to as
the ‘‘Secretary’’) shall carry out a program to pro-
vide information and education to the public regard-
ing uterine fibroids, including information on the in-
cidence and prevalence of such fibroids, and on the
elevated risk for minority women.
(2) 
AUTHORITY
FOR
GRANTS
AND
CON-
TRACTS.—The Secretary may carry out paragraph
(1) directly or through awards of grants, cooperative
agreements, or contracts to public or nonprofit pri-
vate entities.
(3) DEFINITION.—For purposes of this sub-
section, the term ‘‘minority’’, with respect to women,
means women who are members of racial or ethnic
minority groups within the meaning of section 1707
of the Public Health Service Act.
(4) AUTHORIZATION
OF
APPROPRIATIONS.—
For the purpose of carrying out this subsection,
there are authorized to be appropriated such sums
as may be necessary for each of the fiscal years
2002 through 2006. Such authorizations are in addi-
tion to any other authorizations of appropriations
that are available for such purpose.
Æ